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Autism spectrum disorders (ASD) are heterogeneous neurodevelopmental disorders that
are reportedly characterized by aberrant neural networks. Recently developed multiscale
entropy analysis (MSE) can characterize the complexity inherent in electroencephalogra-
phy (EEG) dynamics over multiple temporal scales in the dynamics of neural networks.
We encountered an 18-year-old man with ASD whose refractory catatonic obsessive–
compulsive symptoms were improved dramatically after electroconvulsive therapy (ECT).
In this clinical case study, we strove to clarify the neurophysiological mechanism of ECT
in ASD by assessing EEG complexity using MSE. Along with ECT, the frontocentral region
showed decreased EEG complexity at higher temporal scales, whereas the occipital region
expressed an increase at lower temporal scales. Furthermore, these changes were associ-
ated with clinical improvement associated with the elevation of brain-derived neurotrophic
factor, which is a molecular hypothesis of ECT, playing key roles in ASD pathogenesis.
Changes in EEG complexity in a region-specific and temporal scale-specific manner that we
found might reflect atypical EEG dynamics in ASD. Although MSE is not a direct approach
to measuring neural connectivity and the results are from only a single case, they might
reflect specific aberrant neural network activity and the therapeutic neurophysiological
mechanism of ECT in ASD.
Keywords: autism spectrum disorders, brain-derived neurotrophic factor, EEG complexity, electroconvulsive
therapy, multiscale entropy, obsessive–compulsive disorder
INTRODUCTION
Autism spectrum disorders (ASD) are heterogeneous neurodevel-
opmental disorders that are complicated by the co-existence of and
symptomatic overlap with other psychiatric disorders (Leyfer et al.,
2006). Among other factors, the frequent presence of obsessive–
compulsive symptoms in ASD has been emphasized in earlier
study (Mack et al., 2010). Results of many earlier functional stud-
ies have supported the notion that aberrant neural networks lie
at the heart of ASD and obsessive–compulsive disorders (OCD).
A core neurobiological mechanism that is putatively linked to
ASD symptoms involves aberrant neural connectivity [see reviews
Courchesne and Pierce (2005) and Wass (2011)]. Similarly, neu-
robiological models of OCD have been reported with a circuit
involving orbitofronto-striato-thalamic systems (Remijnse et al.,
2006; Chamberlain et al., 2008). Results of recent neuroimaging
studies have demonstrated that more widely distributed large-
scale brain systems are involved in OCD pathogenesis (Ping et al.,
2013; Piras et al., 2015).
Abbreviations: ASD, autism spectrum disorder; BDNF, brain-derived neurotrophic
factor; BFCRS, Bush–Francis Catatonia Rating Scale; ECT, electroconvulsive ther-
apy; EEG, electroencephalogram; MSE, multiscale entropy; OCD, obsessive–
compulsive disorders; SampEn, sample entropy; SF, scale factor.
Electroconvulsive therapy (ECT) has been widely used for the
treatment of many psychiatric disorders. Although the American
Psychiatric Association task force on ECT states that ECT is not an
effective treatment option for patients with OCD (Frankel, 1990),
reports in the relevant literature have described ECT being effec-
tively used in OCD (Goodman et al., 1993; D’Urso et al., 2012;
Raveendranathan et al., 2012). Additionally, ECT is an effective
alternative for treating coexisting acute phase of catatonia in ASD
when benzodiazepine treatment proves to be insufficient (Zaw
et al., 1999; Wachtel et al., 2008, 2010). Although the underlying
neural mechanisms remain unclear, recent neuroimaging stud-
ies have supported the hypothesis that amelioration of functional
connectivity in neural networks plays a key role in the working
action of ECT (Fosse and Read, 2013).
Electroencephalography (EEG) provides a precise millisecond-
timescale to examine normal and pathologic temporal dynamics.
As reviewed by Billeci et al. (2013), many EEG analysis methods
have been applied, revealing altered neural networks in ASD dur-
ing both rest and specific task conditions using coherence or phase
synchronization analysis.
Neural networks are characterized by dynamical neural com-
munications in functionally specialized assemblies and long-range
mutual interactions across these assemblies (Varela et al., 2001;
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Schnitzler and Gross, 2005; Sporns, 2011). Neurophysiologic out-
put signals derived from EEG therefore exhibit complex temporal
fluctuations that reflect non-linear dynamical processes (Tononi
et al., 1998; Abarbanel and Rabinovich, 2001). The recent non-
linear approaches to characterizing complex temporal dynamics
have provided new insights into EEG dynamical complexity in
mental disorders including ASD (Takahashi, 2013). One approach
to the non-linear estimation of EEG complexity is entropy-based
algorithm. Among entropy-based algorithms, sample entropy
(SampEn) was developed as a practically tractable physiological
complexity measure for evaluating signal regularity or predictabil-
ity (Richman and Moorman, 2000). However, complexity that is
inherent in physiological systems has a more restrictive concept:
complex systems are neither completely regular nor absolutely ran-
dom. Moreover, irregularity does not necessarily correlate with
complexity (Tononi et al., 1998; Costa et al., 2005). Therefore,
SampEn as a measure of irregularity does not imply intrinsic phys-
iological complexity (Costa et al., 2002, 2005). Additionally, as
current neural activity can be influenced by past neural processes
that have been stored dynamically through feedback loops at mul-
tiple hierarchical levels of cortical processing (Fell et al., 2000),
neurophysiologic signals might reflect historic effects on under-
lying dynamics at multiple temporal scales. To investigate the
variation in physiological signals across multiple temporal scales,
Costa et al. (2002) introduced multiscale entropy analysis (MSE),
which is calculated based on SampEn, in recognition of the like-
lihood that the dynamical complexity of biological signals might
operate across a range of temporal scales. Consequently, evaluat-
ing a particular pattern of entropy values across the varying scales
permits the detection of intrinsic complexity. As a consequence,
characterizing the EEG complexity using MSE might add another
dimension to already identified neural dynamics of ASD [see a
review by Billeci et al. (2013)].
We encountered a patient with ASD who, after ECT, exhib-
ited dramatically improved coexisting severe catatonic obsessive–
compulsive symptoms. This study examines changes in EEG com-
plexity with ECT using MSE and its relation to clinical outcomes.
BACKGROUND
PATIENT AND CASE HISTORY
T., an 18-year-old man with ASD, came to our hospital com-
plaining of overall movements slowing. At the age of 14 years,
he was diagnosed with ASD according to the Autism Diagnostic
Interview-Revised (ADI-R) based on the following developmen-
tal history. At age 2, he showed poor eye-contact and repetitive
behaviors, avoiding group play. His repetitive interest was arrang-
ing his toys at equal intervals in a row by himself. He did not
exhibit delayed language development. He had been unable to wear
clothes other than made from soft material because of his hyper-
sensitivity to tactile sensation. At age 6, he developed blinking
tics and worsening of repetitive behaviors. He reportedly showed
average intelligence on IQ tests (full IQ: 106). By the age of 17,
his self-care behavior such as bathing and changing clothes had
become slower. He also developed obsessive–compulsive symp-
toms. He had symmetry obsessions with ordering, arranging,
counting compulsions, ruminations, dwelling on cosmology, and
magical thinking, and tried to dispel them by performing repetitive
rituals such as “rubbing the left ear and then the right elbow.” He
was admitted to a hospital and was prescribed olanzapine. Nev-
ertheless, his symptoms worsened. He would remain immobile
for several hours and would show inability to initiate movements
without prompting from others. Finally, he was transferred to our
hospital, exhibiting catatonic features such as mutism, immobility,
grimacing, negativism, posturing, and stereotypy.
His EEG and brain magnetic resonance imaging showed no
abnormalities. Blood examinations including thyroid function
yielded normal results. Neurological symptoms were also unre-
markable. Escitalopram was started on the olanzapine and titrated
up to 20 mg/day. His catatonic features improved slightly but
remained severely impaired. Then, lorazepam was added up to
3 mg/day. He showed resolution of his catatonic features, which
nevertheless brought him no relief. Because ECT is included
in treatment algorithms for acute phase of catatonia in ASD
(Fink et al., 2006), ECT was selected to gain catatonia remis-
sion. Lorazepam was discontinued to achieve appropriate ECT
efficacy. His catatonic symptoms worsened again after stopping
the lorazepam treatment. Other medications were maintained
throughout the treatments. His response to ECT had been dra-
matic. He was making satisfactory progress, but he experienced
severe headaches as an adverse effect of ECT. Generally, in spite of
ECT’s favorable effect, its maintenance use is limited by the fact
that ECT mostly appears to be beneficial in a temporary man-
ner, except in a few cases (DeJong et al., 2014). Additionally, he
had already demonstrated clinical relief from catatonic features.
For these reasons, ECT was discontinued after a course of seven
ECTs. Unfortunately, he relapsed slowly to obsessive–compulsive
symptoms. Considering the fact that he was not that much more
catatonic than before and that he had severe headaches with ECT,
lorazepam (1.5 mg/day), to which he had responded moderately
in the prior administration, was restarted. His problematic symp-
toms were alleviated. He became able to live independently. He was
therefore discharged from our hospital. As of this writing, after no
relapse for 5 months, he attends a day care center.
T. and his mother gave written informed consent to the pub-
lication of his case. We altered or omitted some details to avoid
identifying the patient.
ELECTROCONVULSIVE THERAPY
This patient was naïve to ECT treatment. Bifrontal ECT was con-
ducted (Thymatron System IV; Somatics LLC, Lake Bluff, IL, USA)
twice a week. The seizure threshold for the first treatment and
mean charge were, respectively, 151.1 and 85.8 mC. The mean
seizure length was 63.29 s. Anesthesia was induced with thiopental
200–250 mg, succinylcholine 40–60 mg, and 100% oxygen. Table 1
presents ECT course details.
EEG RECORDINGS
Electroencephalography activity was recorded with the subject
lying in bed in a dark, soundproof laboratory room with no
mental task. Standard scalp electrodes were placed in accordance
with the International 10–20 System, referenced to linked earlobe
electrodes. The EEG was recorded at a 500 Hz sample frequency
with a 1.5–120 Hz bandpass filter using an 18-channel system
(EEG-1214; Nihon Kohden Corp., Tokyo, Japan). Because of his
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Table 1 | Electroconvulsive therapy (ECT) profiles.
No. of ECT 1 2 3 4 5 6 7
1 2
ECT Seizure threshold for
ECT charge (mC)
30% (151.1) 25% (125.2) 20% (100.1) 15% (74.7) 10% (49.8) 10% (49.8) 5% (49.8) 10% (49.8)
Seizure duration (s) 54 69 55 57 60 70 0 78
Anesthesia Thiopental (mg) 200 200 200 200 200 200 200 200
Succinylcholine (mg) 50 50 60 60 60 60 60 60
hypersensitivity to tactile sensation, we selected eight electrodes
(i.e., F3, F4, C3, C4, P3, P4, O1, and O2), which minimally cover the
brain. Eye movements were monitored using additional electro-
oculographic (EOG) channels. Impedances were maintained at
<5 kΩ. Except for band pass filtering, no other pre-processing step
(i.e., filtering, artifacts removal, or data reconstruction) was con-
ducted because of the likelihood that such processing might distort
non-linearity in the data, which might affect the MSE assessments.
The state of vigilance was visually inspected with EEG traces dur-
ing a recording session. When the subject appeared to be drowsy,
he was asked to open his eyes and was verbally warned to avoid
drowsiness. The selection of segments recorded during eyes-closed
wakefulness was performed by visual inspection of EEG and EOG
recordings. He was regarded as fully awake when alpha activity
appeared predominantly over the posterior regions, with con-
current fast eye movements in the EOG channel (Wada et al.,
1996). Additionally, spectral analysis was performed to confirm
the appearance of alpha activity in O1 and O2 electrode sites. The
EEG was recorded for 20–40 min to obtain two continuous rest-
ing state 30 s segments of data (15,000 data points: 30 s× 500 Hz).
Segments with artifacts such as eye movements, blinks, muscle
activities, and other artifacts were visually identified and were
excluded. The EEG was recorded twice a week for a total of 24
times: pre-treatment (three times), during ECT (7 times), after
ECT (8 times), and treatment with lorazepam (6 times). During
ECT, EEG was performed 48 h after each ECT.
MULTISCALE ENTROPY
The MSE method quantifies the degree of irregularity in a
time series at multiple time scales (Costa et al., 2005). First, to
obtain multiple time scales, the original EEG time series {x1, x2,
. . ., xN} was coarse-grained using the scale factor (SF) τ, with
non-overlapping windows as shown below.
y(τ)j =
(
1upslopeτ
) jτ∑
i=(j−1)τ+1
xi , 1 ≤ j ≤ Nupslopeτ
Second, the irregularity of each coarse-grained EEG time series
{y(τ)} was measured using SampEn, which is well suited for ana-
lyzing short and noisy experimental data (Richman and Moorman,
2000; Richman et al., 2004). SampEn is the negative of the logarith-
mic conditional probability that two sequences of m consecutive
data points, which are mutually similar (within given tolerance r)
will remain similar at the next point (m+ 1) in the dataset (N ),
where N is the length of the time series. Considering the EEG time
series {x1, x2, . . ., xN} as observations of a stochastic variable x,
dynamic SampEn is defined as:
hsamp(r ,m,N ) = − loge [Cm+1(r)/Cm(r)],
where Cm(r) = {number of pairs (i, j)|zmi − zmj | < r , i 6=
j}/{number of all probable pairs, i.e., (N − m + 1) (N − m)} .
Therein, z = y(τ), and zm is a vector of m sample time series of
(N−m) length, and |zmi −zmj |denotes the distance between points
zmi and z
m
j in the space of dimension m, and r is the effective filter
for measuring consistency of time series. For the coarse-grained
time series at SF= 1, the time series {y(1)} was simply identical to
the original time series. The SampEn values for low SFs captured
short-range temporal irregularity, whereas higher SFs captured
long-range temporal irregularity. Consequently, the SampEn val-
ues at smaller SFs were examined specifically for EEG complexity
at high frequencies, whereas larger SFs were examined specifically
at low frequencies. Various theoretical and clinical applications
have shown that m= 1 or 2, and r = 0.1–0.25 of the SD of the data
points provides good statistical validity for SampEn (Lake et al.,
2002; Richman et al., 2004). For the present analyses, we used
m= 2 and r = 0.2, which are values that were applied successfully
in our previous study (Takahashi et al., 2009, 2010; Mizuno et al.,
2010; Okazaki et al., 2013; Ueno et al., 2015).
To index information related to long-range temporal dynam-
ics adequately, the EEG signals used for MSE analysis corre-
sponded to continuous 30 s (15,000 data points), artifact-free
segments selected from eye-closed resting condition, which are
long compared to those used for other EEG analysis methods.
For each subject, MSE was calculated on two segments and aver-
aged into a single value. The MSE calculation was conducted with
self-produced software, developed using a commercially available
software package (Mathematica 8; Wolfram Research, Inc.). To
examine the reproducibility of MSE results from two segments in
the same EEG session, the Pearson product–moment correlation
coefficients across ECT sessions were calculated. As a result, cor-
relation coefficients were 0.87 for the frontal, 0.80 for the central,
and 0.93 for the occipital region.
POWER SPECTRUM ANALYSIS
In addition to MSE analysis, we performed power spectrum analy-
sis as a comparative, more conventional EEG analysis, using a com-
puter program (Brain Vision Analyzer 2; Brain Products GmbH,
Germany). The spectral density was calculated using a fast Fourier
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transform (FFT). A Hanning window was applied to each 2 s epoch
selected from 30 s artifact-fee segments that was also used for MSE
calculation (i.e., a total segments for FFT was 15). In Figure 1, the
absolute power spectrum values were log-transformed.
CLINICAL ASSESSMENT AND BRAIN-DERIVED NEUROTROPHIC FACTOR
His severe obsessive–compulsive symptoms presented catatonic
features. Therefore, the Bush–Francis Catatonia Rating Scale
(BFCRS; Bush et al., 1996) was administered for clinical assess-
ments. We examined the serum concentrations of brain-derived
neurotrophic factor (BDNF) because BDNF is a central part of the
molecular hypothesis of ECT (Sartorius et al., 2009) and because
it plays key roles in the pathogenesis of both ASD (Das, 2013) and
OCD (Wang et al., 2011).
RESULTS
A remarkable change of EEG complexity was observed in asso-
ciation with ECT treatment (Figure 1). At smaller SFs (i.e., light
pink shaded area), the EEG complexity was decreased especially
in the frontal and central regions. By contrast, at larger SFs (i.e.,
light blue shaded area), EEG complexity was increased especially
in occipital regions. After ECT, these changes tend to revert to the
level prevailing before treatment, but they remained, respectively,
lower and higher. To clarify the possible association of the clini-
cal course (BCRF and BDNF) with EEG complexity, we averaged
SampEn values of SF 1–5 (i.e., light pink shaded area in Figure 1)
for F3, F4, C3, and C4, and SF31–40 (i.e., light blue shaded area
in Figure 1) for O1 and O2 into one value. Figure 2 presents a
summary of the associations of changes in clinical course (BCRF
and BDNF) to EEG complexity. In contrast to MSE, power spec-
trum analysis showed a power density decrease with ECT in the
slow frequency range from theta to alpha, which was increased
to the level of before treatment again, whereas the fast frequency
range from beta to gamma showed a decrease with ECT, which
tended to remain lower (Figure 1). This trend was observed for all
electrode sites. Marked association is apparent between the EEG
complexity and clinical improvement and BDNF level. However,
the administration of lorazepam did not affect EEG complexity
despite clinical improvement. Figure 3 presents scatter plot asso-
ciations of clinical course (BCRF and BDNF) and EEG complexity
(compare middle and bottom panel; data obtained after treatment
with lorazepam were eliminated from the middle panel).
DISCUSSION
This report is the first describing ECT-induced change of
the EEG complexity in a patient with ASD and coexisting
obsessive–compulsive symptoms. Specifically, the frontocentral
region showed a decrease in EEG complexity at lower SFs. How-
ever, the occipital region showed an increase at higher SFs. Our
findings of increased and decreased EEG complexity in a region-
specific and temporal scale-specific manner associated with clin-
ical improvement and BDNF level might reflect atypical EEG
dynamics in ASD.
A growing number of EEG and magnetoencephalogra-
phy (MEG) reports describe abnormal neural connectivity
with a region-specific and temporal scale-specific manner, and
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FIGURE 1 | Results of multiscale entropy (MSE) analysis (upper panel)
and power spectrum analysis (lower panel) conducted before
electroconvulsive therapy (ECT), during ECT, after ECT, and during
treatment with lorazepam. Each panel shows averaged MSE and power
spectrum results from each condition. A decrease in sample entropy
(SampEn) was observed with ECT at lower scale factors (SFs) 1–5
(highlighted with light pink shaded area). By contrast, increased SampEn was
observed at higher SFs 31–40 (light blue shaded area).
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FIGURE 2 | Results from sample entropy (SampEn) values. In the upper
and middle panels, each bar shows averaged SampEn values of SF 1–5 (i.e.,
light pink shaded area in Figure 1) and for the frontal and central regions
(F3, F4, C3, and C4). Each bar in the lower panel shows averaged SampEn
values of SF 31–40 (i.e., light blue shaded area in Figure 1) for the occipital
region (O1 and O2). Each condition was identified by color: before-ECT as
the blue bar, during-ECT as the yellow bar, after-ECT as the green bar, and
during treatment with lorazepam as the light blue bar. Regarding the clinical
course, the black circle shows the Bush–Francis Catatonia Rating Scale
(BFCRF). The vertical axis on the right shows the scale of the BFCRS score.
The black arrow below the horizontal axis shows the serum concentration
of BDNF.
underpinned the concept of aberrant neural network in ASD [for
a review, see Billeci et al. (2013)]. In terms of EEG–MSE study,
Catarino et al. (2011) reported considerable reduction of EEG
complexity in young subjects with ASD as the temporal scale
increases, over temporoparietal and occipital regions. Additionally,
reduced EEG complexity at higher temporal scales was reported
in infants who were at high risk for autism, especially in the 9–
24 months range, with 80% accuracy in discriminating high risk
for autism subjects from normally developed infants (Bosl et al.,
2011). Furthermore, region-specific and temporal scale-specific
alterations were reported in patients with ASD in a resting-state
MEG study (Ghanbari et al., 2015). Although our study exam-
ined only a single case and although it is limited by its lack
of comparison with healthy controls, results described in these
previous reports agree at least partially with our findings. This
report describes a remarkable decrease of EEG complexity with
ECT associated with clinical improvement in patients with depres-
sion, but this was apparent only at lower temporal scales (Okazaki
et al., 2013). In this context, changes in EEG complexity at lower
temporal scales in the frontal region might be due to the direct
effects of ECT across mental diseases, although changes in the
occipital region at higher temporal scales might be more specific
to ASD’s neuropathophysiology, including obsessive–compulsive
symptoms.
Potential limitations of our study must be considered. First,
the influence of medications on MSE results must be considered
because our patient had been consistently prescribed olanzapine
and escitalopram during ECTs. In fact, we previously reported
a significant EEG complexity decrease at higher temporal scales
with typical antipsychotics in patients with schizophrenia, espe-
cially in the frontal region (Takahashi et al., 2010). Therefore,
the possibility of psychotropic agent effects on EEG complexity
must be discussed. However, medications of our case were main-
tained throughout the EEG examinations, except for lorazepam.
We assume that the EEG complexity change should be a result
of ECT. Second, the regional specificity described above must
be discussed carefully. We examined only eight electrodes. Addi-
tionally, the electrical activity in each scalp electrode might not
have its origin in the brain area directly underneath the electrode.
Therefore, it is difficult to infer the precise spatial distribution
of regional changes. Another important question remains: how is
EEG complexity related to neural hyper-connectivity and hypo-
connectivity? To elucidate the relation between EEG complexity
to neuronal networks, Friston (1996) assessed the effect of the
degree of neural connectivity within neuronal populations and
measures of complexity using synthetic neuronal models, finding
that reduced connectivity increases EEG signal complexity. Sev-
eral reports in the literature have described investigations of neural
connectivity and complexity. In healthy adolescents,Anokhin et al.
(1999) investigated relations between global EEG dynamics and
intelligence using EEG coherence and dimensional complexity,
with the expectation that “coherence and dimensional complex-
ity would be inversely correlated.” They found inverse correlation
between coherence and dimensional complexity. In mental dis-
orders, Jelles et al. (2008) investigate the relation between EEG
coherence and correlation dimension in Alzheimer’s disease, and
therefore, to gain further insight into the “disconnection” hypoth-
esis of cognitive dysfunction in this disorder. The finding was that
coherence and correlation dimensions are inversely correlated.
Ghanbari et al. (2015) jointly examined MSE and synchronization
likelihood to obtain a more detailed characterization of resting-
state MEG activity in ASD. It is particularly interesting that group
differences between ASD and typically developed subject in com-
plexity and synchronization appear spatially complementary, such
that where synchronization was elevated in ASD, complexity was
reduced (and vice versa). In this sense, hyper-connectivity and
low-complexity might be mutually related.
Taken together, the exact relation between complexity and the
degree of connectivity remains unexplained and is open to debate,
especially when discussing the complexity behavior and its rela-
tions to a spatial distribution of connectivity. Consequently, com-
plementary techniques with better spatial resolution (e.g., MEG)
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FIGURE 3 | Scatter plot associations of BDNF (top panel), BCRF (middle and bottom panel), and EEG complexity. Compare middle and bottom panel;
data obtained after treatment with lorazepam were eliminated from the middle panel.
and a direct measure of neural connectivity (e.g., mutual entropy
or Omega-complexity) are necessary to obtain more precise infer-
ences of complexity and connectivity. However, MSE analysis
might provide additional insights into the role of specific neural
dynamics, possibly reflecting the specific aberrant neural network
activity, and the therapeutic neurophysiological mechanism of
ECT in ASD. Furthermore, MSE might be useful as a benchmark
of the therapeutic efficacy of ECT for patients with ASD.
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